Risk factors for combined hepatocellular-cholangiocarcinoma: A hospital-based case-control study

被引:28
|
作者
Zhou, Yan-Ming [1 ]
Zhang, Xiao-Feng [2 ]
Wu, Lu-Peng [1 ]
Sui, Cheng-Jun [2 ]
Yang, Jia-Mei [2 ]
机构
[1] Xiamen Univ, Affiliated Hosp 1, Dept Hepatobiliary Pancreatovasc Surg, Xiamen 361003, Fujian Province, Peoples R China
[2] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Special Treatment & Liver Transplantat, Shanghai 200438, Peoples R China
关键词
Risk factors; Combined hepatocellular-cholangiocarcinoma; Hepatitis B virus; Alcohol consumption; Epidemiology; HEPATIC PROGENITOR CELLS; PRIMARY LIVER CANCERS; B-VIRUS INFECTION; INTRAHEPATIC CHOLANGIOCARCINOMA; CLINICAL-FEATURES; CLINICOPATHOLOGICAL CHARACTERISTICS; COMPUTED-TOMOGRAPHY; PROGNOSTIC-FACTORS; DIABETES-MELLITUS; CARCINOMA;
D O I
10.3748/wjg.v20.i35.12615
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To identify risk factors contributing to the development of combined hepatocellular-cholangiocarcinoma (CHC) in China. METHODS: One hundred and twenty-six patients with CHC and 4:1 matched healthy controls were interviewed during the period from February 2000 to October 2012. Logistic regression analysis was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for each risk factor. RESULTS: Univariate analysis showed that the significant risk factors for CHC development were hepatitis B virus (HBV) infection, heavy alcohol consumption, a family history of liver cancer, and diabetes mellitus. Multivariate stepwise logistic regression analysis showed that HBV infection (OR = 19.245, 95% CI: 13.260-27.931) and heavy alcohol consumption (OR = 2.186, 95% CI: 1.070-4.466) were independent factors contributing to the development of CHC. CONCLUSION: HBV infection and heavy alcohol consumption may play a role in the development of CHC in China. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:12615 / 12620
页数:6
相关论文
共 50 条
  • [31] Risk Factors for Cervical Cancer: Results from a Hospital-Based Case-Control Study
    Reis, Nesrin
    Beji, Nezihe K.
    Kilic, Dilek
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2011, 21 (03): : 153 - 159
  • [32] Risk factors for pulmonary embolism in a Japanese population: Hospital-based case-control study
    Yamada, Norikazu
    Ota, Satoshi
    Liu, Ying
    Crane, Martin M.
    Nakamura, Mashio
    Ito, Masaaki
    CHEST, 2007, 132 (04) : 629S - 629S
  • [33] Risk factors of pancreatic cancer in Vietnam: A matched case-control hospital-based study
    Dao, Tu V.
    Tran, Thuan V.
    Nguyen, Dung K.
    Bui, Oanh T.
    Nguyen, Quang T.
    Tran, Huong T.
    CANCER RESEARCH, 2020, 80 (16)
  • [34] Prenatal and perinatal risk factors and testicular cancer: A hospital-based case-control study
    Sonke, Gabe S.
    Chang, Shine
    Strom, Sara S.
    Sweeney, Anne M.
    Annegers, J. Fred
    Sigurdson, Alice J.
    ONCOLOGY RESEARCH, 2007, 16 (08) : 383 - 387
  • [35] Risk factors for multiple myeloma: A hospital-based case-control study in Northwest China
    Wang, Qixia
    Wang, Yiwei
    Ji, Zhaohua
    Chen, Xiequn
    Pan, Yaozhu
    Gao, Guangxun
    Gu, Hongtao
    Yang, Yang
    Choi, Bernard C. K.
    Yan, Yongping
    CANCER EPIDEMIOLOGY, 2012, 36 (05) : 439 - 444
  • [36] Prevalence and risk factors of anterior subcapsular cataract in a hospital-based case-control study
    Kim, H
    Park, JW
    Joo, CK
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U303 - U303
  • [37] Risk factors and therapy for goat mastitis in a hospital-based case-control study in Bangladesh
    Koop, Gerrit
    Islam, Md. Nurul
    Rahman, Md. Mizanur
    Khatun, Momena
    Ferdous, Jinnat
    Abu Sayeed, Md.
    Islam, Shariful
    Ahaduzzaman, Md.
    Akter, Sazeda
    Mannan, Abdul
    Hassan, Mohammad Mahmudul
    Dissanayake, Ravi
    Hoque, Md. Ahasanul
    PREVENTIVE VETERINARY MEDICINE, 2016, 124 : 52 - 57
  • [38] Risk Factors for Ovarian Cancer: Results from a Hospital-Based Case-Control Study
    Reis, Nesrin
    Beji, Nezihe Kizilkaya
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2010, 30 (01): : 79 - 87
  • [39] Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma
    Chen, Xiaoyuan
    Lu, Yiwei
    Shi, Xiaoli
    Chen, Xuejiao
    Rong, Dawei
    Han, Guoyong
    Zhang, Long
    Ni, Chuangye
    Zhao, Jie
    Gao, Yun
    Wang, Xuehao
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [40] Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study
    Kamsa-Ard, Supot
    Luvira, Vor
    Pugkhem, Ake
    Luvira, Varisara
    Thinkhamrop, Bandit
    Suwanrungruang, Krittika
    Bhudhisawasdi, Vajarabhongsa
    BMC CANCER, 2015, 15